Skip to main content

Table 6 Relative size of incentive payments to revenue

From: Is the evidence on the effectiveness of pay for performance schemes in healthcare changing? Evidence from a meta-regression analysis

Scheme, study Country Payment/Revenue (%)
Spontaneous breathing trials (SBTs), [8] US 7.5
CAPI-ROSP, [9,10,11] France 4–7
Rwanda P4P, [12] Rwanda 22
P4P for Maternal care, [13,14,15] Tanzania 10–25
P4P for Antibiotics, [16] Sweden 0.05–1.2
Quality and Outcomes Framework, [17] UK 25
Afghanistan P4P, [18] Afghanistan 6–28